Janus Henderson Group plc 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:37 pm Sale |
2024-12-31 | 13G | Tenax Therapeutics, Inc. TENX |
JANUS HENDERSON GROUP PLC JHG |
193,182 5.400% |
-166,666 (-46.32%) |
Filing |
| 2024-11-14 12:39 pm Unchanged |
2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX |
JANUS HENDERSON GROUP PLC JHG |
359,848 10.000% |
0 (Unchanged) |
Filing |
| 2024-08-14 3:19 pm Purchase |
2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX |
JANUS HENDERSON GROUP PLC JHG |
359,848 9.900% |
359,848 (New Position) |
Filing |